Patrick Sartore - ProMetic Life Insider

PJ2 -- Germany Stock  

EUR 0.39  0.028  7.82%

Senior Legal Counsel, Corporate Secretary

Mr. Patrick Sartore is a Chief Legal Officer and Corporationrationrate Secretary of the Company. Mr. Patrick Sartore joined Prometic in 2006 as Senior Legal Counsel Intellectual Property, was nominated Corporationrationrate Secretary of the Corporationrationration in 2007. Mr. Sartore held the position of General Counsel and Corporationrationrate Secretary from May 2013 to May 2015, at which date he was appointed Chief Legal Officer and Corporationrationrate Secretary. Mr. Sartore was previously employed by Univalor Inc. as Legal Counsel and Leger Robic Richard, L.L.P., a firm specializing in Intellectual Property, Corporationrationrate and Commercial Law, as an associate attorney. Mr. Sartore has extensive experience in the areas of intellectual property, technology transfer, licensing and commercialization, private and public financing as well as general corporate and commercial law, namely in the biopharmaceutical field. Mr. Sartore graduated from the University of Montreal with a Bachelor of Law in 1999 and was called to the Bar of Qubec in 2001
  Executive Since 2015      
450-781-0115  http://www.prometic.com
Sartore also holds a BS, with Distinction, from Concordia University.

Management Efficiency

The company has return on total asset (ROA) of (29.29) % which means that it has lost $29.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (91.76) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 85.93 M in total debt with debt to equity ratio (D/E) of 91.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProMetic Life Sciences has Current Ratio of 1.83 which is within standard range for the sector.

Similar Executives

Entity Summary

ProMetic Life Sciences Inc., a biopharmaceutical company, develops bioseparations, plasma-derived therapeutics, and small-molecule therapeutic products. ProMetic Life Sciences Inc. was founded in 1992 and is headquartered in Laval, Canada. ProMetic Life operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 480 people.ProMetic Life Sciences (PJ2) is traded on Frankfurt Stock Exchange in Germany. It is located in 440, Boulevard Armand-Frappier and employs 480 people.

ProMetic Life Sciences Leadership Team

Nancy Orr, Director
Louise Menard, Director
Simon Best, Chairman, MBA
Steve Burton, CEO, Ph.D
Andrew Bishop, Director, MBA
Patrick Sartore, Executive
DwunHou Chen, President, Ph.D
Bruce Wendel, Director
Gregory Weaver, CFO, CPA
Pierre Laurin, CEO
John Moran, Director, Ph.D
Stefan Clulow, Director
Kenneth Galbraith, Director
Bruce Pritchard, CFO
Benjamin Wygodny, Director
Raymond Hakim, Director
Charles Kenworthy, Director
Paul Mesburis, Director, MBA
Frederic Dumais, Director

Stock Performance Indicators

Did you try this?

Run Fundamentals Matrix Now
   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Fundamentals Matrix

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.